Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Ben on +44 1494 818005 or Ben@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Ben Chadwick
Team Leader
Ben@zenopa.com
+44 1494 818005

Testimonials
I have used several Pharmaceutical Recruitment agencies over the last two years, as I do not come from a science background or have any selling experience within the industry I found it extremely hard...
Adam, 2011

Janssen wins five prizes at PM Society Digital Media Awards

10 October 2011 00:00 in Pharmaceutical Company Product News


Janssen has won a total of five accolades for its marketing initiatives at the PM Society's recent Digital Media Awards event.

The company was the most decorated pharmaceuticals firm at the industry awards show, with its 2011 haul exceeding its total of three wins last year, reports InPharm.

Its Psoriasis 360 social media campaign - conducted in association with advertising agency Creative Lynx - was strongly praised, claiming the titles of best integrated campaign and best digital patient communications programme.

The Psoriasis eLearning Programme, also led by Creative Lynx with the support of Doctors.net.uk, won best healthcare provider education programme, while the firm's Shaping a Future video won the Craft Award for innovation.

In addition, Janssen's Shaping Futures, Enabling Lives digital selling tool - designed to promote its schizophrenia brand Xeplion - won the best rep-led digital selling tool award, with judges praising it for its return on investment.

Last month, the company expanded its product range in the UK with the launch of Zytiga, an EU-approved once-daily oral therapy for advanced prostate cancer.ADNFCR-8000103-ID-800753121-ADNFCR

Other news stories from 10/10/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd